Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for TAL1
Z-value: 11.48
Motif logo
Transcription factors associated with TAL1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TAL1
|
ENSG00000162367.11 | TAL1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| TAL1 | hg38_v1_chr1_-_47231715_47231786 | 0.31 | 4.0e-06 | Click! |
Activity profile of TAL1 motif
Sorted Z-values of TAL1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of TAL1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 13.2 | 39.5 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 12.9 | 167.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 12.8 | 38.3 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 12.6 | 37.8 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 11.6 | 34.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 10.7 | 53.5 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 10.6 | 42.2 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 10.5 | 20.9 | GO:0002445 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
| 9.6 | 9.6 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
| 9.6 | 38.4 | GO:1903611 | regulation of calcium-dependent ATPase activity(GO:1903610) negative regulation of calcium-dependent ATPase activity(GO:1903611) regulation of dUTP diphosphatase activity(GO:1903627) positive regulation of dUTP diphosphatase activity(GO:1903629) negative regulation of aminoacyl-tRNA ligase activity(GO:1903631) regulation of leucine-tRNA ligase activity(GO:1903633) negative regulation of leucine-tRNA ligase activity(GO:1903634) |
| 9.6 | 67.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 9.4 | 28.2 | GO:1905237 | response to cyclosporin A(GO:1905237) |
| 9.3 | 37.3 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 8.9 | 26.6 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 8.8 | 35.4 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 8.6 | 25.8 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 8.5 | 25.4 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
| 8.4 | 1183.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 8.3 | 33.3 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 8.3 | 41.5 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 8.2 | 24.5 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 7.9 | 39.6 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
| 7.7 | 30.9 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 7.6 | 15.2 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 7.6 | 45.3 | GO:2000405 | negative regulation of T cell migration(GO:2000405) |
| 7.3 | 29.3 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 7.3 | 29.1 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 7.1 | 21.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 6.9 | 20.8 | GO:0061699 | protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 6.9 | 34.5 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 6.7 | 33.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 6.7 | 13.4 | GO:1902623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 6.6 | 19.9 | GO:0070078 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
| 6.6 | 19.7 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 6.5 | 6.5 | GO:0005985 | sucrose metabolic process(GO:0005985) |
| 6.1 | 36.4 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 6.0 | 18.1 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 5.9 | 29.5 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 5.9 | 47.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 5.9 | 23.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 5.8 | 5.8 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 5.7 | 17.0 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 5.7 | 11.3 | GO:0036269 | swimming behavior(GO:0036269) |
| 5.7 | 22.6 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 5.6 | 5.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 5.6 | 16.7 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 5.5 | 5.5 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 5.4 | 16.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 5.3 | 26.4 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 5.2 | 15.6 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 5.2 | 41.4 | GO:0015747 | urate transport(GO:0015747) |
| 5.1 | 10.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 5.1 | 30.8 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 5.1 | 20.5 | GO:0010193 | response to ozone(GO:0010193) |
| 5.1 | 15.3 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
| 5.1 | 10.2 | GO:0034699 | response to luteinizing hormone(GO:0034699) |
| 5.0 | 20.1 | GO:1904640 | response to methionine(GO:1904640) |
| 5.0 | 59.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 5.0 | 14.9 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 5.0 | 14.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 4.9 | 9.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 4.8 | 9.7 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 4.8 | 14.4 | GO:0008355 | olfactory learning(GO:0008355) |
| 4.8 | 14.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 4.8 | 52.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 4.7 | 14.1 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 4.7 | 4.7 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
| 4.7 | 14.0 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 4.7 | 4.7 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 4.6 | 23.0 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 4.6 | 4.6 | GO:0042938 | dipeptide transport(GO:0042938) |
| 4.6 | 18.4 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 4.5 | 13.6 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 4.5 | 4.5 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 4.5 | 8.9 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 4.5 | 8.9 | GO:0046959 | habituation(GO:0046959) |
| 4.5 | 26.7 | GO:0001554 | luteolysis(GO:0001554) |
| 4.4 | 13.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 4.4 | 17.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 4.3 | 8.7 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 4.3 | 8.7 | GO:0002215 | defense response to nematode(GO:0002215) |
| 4.3 | 21.7 | GO:0032571 | response to vitamin K(GO:0032571) |
| 4.3 | 8.7 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 4.3 | 51.9 | GO:0060992 | response to fungicide(GO:0060992) |
| 4.3 | 12.8 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 4.3 | 21.4 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 4.3 | 12.8 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 4.2 | 12.7 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 4.2 | 12.6 | GO:0001300 | chronological cell aging(GO:0001300) |
| 4.2 | 8.4 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 4.2 | 25.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 4.2 | 12.5 | GO:1903565 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 4.1 | 12.4 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 4.1 | 74.4 | GO:0015671 | oxygen transport(GO:0015671) |
| 4.1 | 20.6 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 4.1 | 12.3 | GO:0100009 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 4.1 | 4.1 | GO:0010958 | regulation of amino acid import(GO:0010958) regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 4.1 | 40.8 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 4.1 | 16.3 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 4.1 | 4.1 | GO:0097017 | cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) renal protein absorption(GO:0097017) regulation of metanephric mesenchymal cell migration(GO:2000589) |
| 4.0 | 16.2 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 4.0 | 8.0 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 4.0 | 15.9 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
| 4.0 | 11.9 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 4.0 | 15.8 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) late viral transcription(GO:0019086) |
| 3.9 | 11.8 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 3.9 | 31.4 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 3.9 | 27.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 3.9 | 11.7 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 3.9 | 66.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 3.9 | 3.9 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
| 3.9 | 19.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 3.9 | 3.9 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 3.8 | 11.5 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 3.8 | 15.4 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
| 3.8 | 15.4 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 3.8 | 15.3 | GO:0060023 | soft palate development(GO:0060023) |
| 3.8 | 7.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
| 3.7 | 37.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 3.7 | 11.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 3.7 | 11.0 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
| 3.7 | 14.7 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 3.7 | 14.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 3.6 | 10.9 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 3.6 | 47.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 3.6 | 10.9 | GO:0060005 | vestibular reflex(GO:0060005) |
| 3.6 | 21.5 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
| 3.6 | 25.1 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 3.5 | 13.9 | GO:0052509 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 3.5 | 13.9 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 3.5 | 13.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 3.5 | 3.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 3.4 | 13.8 | GO:0072011 | glomerular endothelium development(GO:0072011) |
| 3.4 | 6.9 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 3.4 | 10.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 3.4 | 10.2 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 3.4 | 13.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 3.4 | 37.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 3.4 | 13.5 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 3.4 | 10.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 3.4 | 6.7 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
| 3.4 | 10.1 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 3.3 | 13.3 | GO:0035106 | operant conditioning(GO:0035106) |
| 3.3 | 10.0 | GO:0034148 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) |
| 3.3 | 10.0 | GO:0006524 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 3.3 | 19.8 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
| 3.3 | 22.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 3.2 | 9.7 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 3.2 | 9.7 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 3.2 | 22.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 3.2 | 12.8 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 3.2 | 15.9 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
| 3.2 | 12.7 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 3.2 | 9.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 3.2 | 9.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 3.1 | 12.5 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
| 3.1 | 6.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 3.1 | 18.5 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 3.1 | 15.4 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
| 3.1 | 21.5 | GO:2000698 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 3.0 | 12.1 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 3.0 | 9.1 | GO:0002818 | intracellular defense response(GO:0002818) |
| 3.0 | 3.0 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 3.0 | 6.0 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 3.0 | 29.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 3.0 | 3.0 | GO:0051182 | coenzyme transport(GO:0051182) |
| 3.0 | 8.9 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 3.0 | 23.7 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 3.0 | 14.8 | GO:0090212 | negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 2.9 | 11.8 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 2.9 | 26.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 2.9 | 23.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 2.9 | 8.8 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen(GO:0002583) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 2.9 | 26.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 2.9 | 8.7 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 2.9 | 23.2 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 2.9 | 8.7 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 2.9 | 5.8 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 2.9 | 11.6 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
| 2.9 | 8.7 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 2.9 | 8.6 | GO:0090274 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 2.9 | 40.2 | GO:0015074 | DNA integration(GO:0015074) |
| 2.9 | 8.6 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 2.9 | 5.7 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 2.8 | 45.4 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 2.8 | 2.8 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 2.8 | 11.3 | GO:0002331 | pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
| 2.8 | 2.8 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 2.8 | 22.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 2.8 | 16.8 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 2.8 | 8.4 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 2.8 | 16.7 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 2.8 | 52.5 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 2.8 | 27.5 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 2.7 | 11.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 2.7 | 21.8 | GO:0042148 | strand invasion(GO:0042148) |
| 2.7 | 29.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 2.7 | 5.4 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 2.7 | 8.1 | GO:0021897 | negative regulation of neuroblast proliferation(GO:0007406) forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 2.7 | 13.4 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 2.7 | 8.0 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 2.7 | 2.7 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
| 2.7 | 10.7 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 2.7 | 13.3 | GO:0001555 | oocyte growth(GO:0001555) regulation of progesterone secretion(GO:2000870) |
| 2.7 | 8.0 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 2.7 | 10.6 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
| 2.6 | 10.6 | GO:0002384 | hepatic immune response(GO:0002384) |
| 2.6 | 18.5 | GO:0015705 | iodide transport(GO:0015705) |
| 2.6 | 26.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 2.6 | 28.7 | GO:0045008 | depyrimidination(GO:0045008) |
| 2.6 | 13.0 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 2.6 | 18.1 | GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
| 2.6 | 7.7 | GO:0034769 | basement membrane disassembly(GO:0034769) |
| 2.6 | 5.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
| 2.6 | 15.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 2.5 | 12.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 2.5 | 2.5 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 2.5 | 17.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 2.5 | 25.1 | GO:0071265 | L-methionine biosynthetic process(GO:0071265) |
| 2.5 | 7.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 2.5 | 5.0 | GO:1901523 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 2.5 | 7.5 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 2.5 | 5.0 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) disaccharide biosynthetic process(GO:0046351) |
| 2.5 | 9.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 2.5 | 4.9 | GO:0015870 | acetylcholine transport(GO:0015870) |
| 2.4 | 2.4 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 2.4 | 7.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 2.4 | 9.8 | GO:2000364 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 2.4 | 7.3 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 2.4 | 19.5 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 2.4 | 9.7 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 2.4 | 7.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 2.4 | 19.2 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 2.4 | 14.3 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 2.4 | 9.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 2.4 | 9.5 | GO:0032431 | positive regulation of phospholipase A2 activity(GO:0032430) activation of phospholipase A2 activity(GO:0032431) |
| 2.4 | 11.9 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
| 2.4 | 4.7 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
| 2.4 | 7.1 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
| 2.4 | 7.1 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 2.4 | 7.1 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
| 2.4 | 14.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 2.4 | 9.4 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 2.3 | 32.9 | GO:0060174 | limb bud formation(GO:0060174) |
| 2.3 | 14.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 2.3 | 9.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 2.3 | 4.7 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 2.3 | 16.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 2.3 | 30.3 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 2.3 | 7.0 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
| 2.3 | 7.0 | GO:0060775 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) mesonephric duct development(GO:0072177) |
| 2.3 | 16.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 2.3 | 46.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 2.3 | 13.8 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 2.3 | 11.4 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 2.3 | 9.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 2.3 | 9.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 2.3 | 13.6 | GO:0015840 | urea transport(GO:0015840) |
| 2.3 | 6.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 2.3 | 13.5 | GO:0018377 | protein myristoylation(GO:0018377) |
| 2.3 | 4.5 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 2.3 | 6.8 | GO:0051414 | response to cortisol(GO:0051414) |
| 2.2 | 6.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 2.2 | 8.9 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
| 2.2 | 6.7 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 2.2 | 8.9 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 2.2 | 13.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 2.2 | 2.2 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 2.2 | 17.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 2.2 | 15.3 | GO:0071315 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 2.2 | 4.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 2.2 | 2.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
| 2.2 | 24.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 2.2 | 2.2 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
| 2.2 | 8.7 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 2.2 | 12.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 2.1 | 4.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 2.1 | 10.7 | GO:1902990 | G-quadruplex DNA unwinding(GO:0044806) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 2.1 | 19.2 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 2.1 | 12.8 | GO:1903061 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 2.1 | 10.6 | GO:2001295 | malonyl-CoA metabolic process(GO:2001293) malonyl-CoA biosynthetic process(GO:2001295) |
| 2.1 | 59.5 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 2.1 | 12.7 | GO:1903232 | melanosome assembly(GO:1903232) |
| 2.1 | 23.3 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 2.1 | 12.7 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
| 2.1 | 10.5 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 2.1 | 8.4 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 2.1 | 31.5 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 2.1 | 16.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 2.1 | 14.7 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 2.1 | 8.4 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 2.1 | 4.2 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
| 2.1 | 10.4 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 2.1 | 6.2 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 2.1 | 6.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 2.1 | 2.1 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 2.1 | 2.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 2.1 | 6.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 2.0 | 4.1 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 2.0 | 16.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 2.0 | 4.1 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 2.0 | 8.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 2.0 | 4.1 | GO:0002001 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
| 2.0 | 8.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 2.0 | 14.1 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 2.0 | 6.0 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 2.0 | 28.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 2.0 | 14.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 2.0 | 18.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 2.0 | 4.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 2.0 | 10.0 | GO:0035624 | receptor transactivation(GO:0035624) |
| 2.0 | 12.0 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
| 2.0 | 4.0 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
| 2.0 | 320.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 2.0 | 6.0 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) |
| 2.0 | 6.0 | GO:0071529 | cementum mineralization(GO:0071529) |
| 2.0 | 4.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 2.0 | 11.9 | GO:0016926 | protein desumoylation(GO:0016926) |
| 2.0 | 7.9 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 2.0 | 5.9 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 2.0 | 3.9 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 2.0 | 3.9 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 1.9 | 21.3 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 1.9 | 27.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 1.9 | 11.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 1.9 | 3.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 1.9 | 1.9 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 1.9 | 9.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 1.9 | 13.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 1.9 | 19.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 1.9 | 15.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 1.9 | 24.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 1.9 | 11.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 1.9 | 45.5 | GO:0045730 | respiratory burst(GO:0045730) |
| 1.9 | 9.5 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 1.9 | 5.7 | GO:0009996 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) negative regulation of cell fate specification(GO:0009996) endocardium formation(GO:0060214) |
| 1.9 | 7.5 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
| 1.9 | 20.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 1.9 | 7.4 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 1.9 | 3.7 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.9 | 27.8 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 1.8 | 7.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 1.8 | 25.9 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 1.8 | 79.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 1.8 | 44.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 1.8 | 1.8 | GO:0019627 | urea metabolic process(GO:0019627) |
| 1.8 | 5.5 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 1.8 | 122.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 1.8 | 1.8 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
| 1.8 | 14.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 1.8 | 14.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 1.8 | 53.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 1.8 | 16.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 1.8 | 21.3 | GO:0044241 | lipid digestion(GO:0044241) |
| 1.8 | 1.8 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 1.8 | 3.5 | GO:0003290 | atrial septum secundum morphogenesis(GO:0003290) |
| 1.8 | 5.3 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 1.8 | 24.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 1.8 | 3.5 | GO:0048852 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
| 1.8 | 7.0 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 1.8 | 17.5 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 1.7 | 45.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 1.7 | 1.7 | GO:1904438 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
| 1.7 | 7.0 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.7 | 24.2 | GO:0060736 | prostate gland growth(GO:0060736) |
| 1.7 | 10.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 1.7 | 29.3 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 1.7 | 37.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 1.7 | 15.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 1.7 | 3.4 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 1.7 | 10.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 1.7 | 8.4 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 1.7 | 11.8 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 1.7 | 35.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 1.7 | 10.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 1.7 | 5.0 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 1.6 | 4.9 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 1.6 | 24.7 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 1.6 | 4.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.6 | 26.3 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 1.6 | 6.5 | GO:2000314 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 1.6 | 17.9 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 1.6 | 55.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 1.6 | 6.5 | GO:0009305 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 1.6 | 35.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 1.6 | 4.8 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 1.6 | 3.2 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 1.6 | 19.1 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 1.6 | 4.8 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) response to fluoride(GO:1902617) |
| 1.6 | 6.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 1.6 | 1.6 | GO:0089718 | amino acid import across plasma membrane(GO:0089718) L-glutamate import across plasma membrane(GO:0098712) |
| 1.6 | 12.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 1.6 | 85.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 1.6 | 3.1 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 1.6 | 32.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 1.6 | 15.7 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 1.6 | 29.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 1.6 | 6.2 | GO:0070316 | regulation of G0 to G1 transition(GO:0070316) |
| 1.6 | 35.7 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 1.5 | 3.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 1.5 | 15.5 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 1.5 | 4.6 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
| 1.5 | 12.4 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 1.5 | 3.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 1.5 | 4.6 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 1.5 | 6.1 | GO:0002819 | regulation of adaptive immune response(GO:0002819) |
| 1.5 | 13.8 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 1.5 | 4.6 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 1.5 | 6.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 1.5 | 6.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 1.5 | 18.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
| 1.5 | 74.4 | GO:0006953 | acute-phase response(GO:0006953) |
| 1.5 | 6.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 1.5 | 3.0 | GO:0035565 | regulation of pronephros size(GO:0035565) |
| 1.5 | 4.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 1.5 | 3.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 1.5 | 3.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
| 1.5 | 9.0 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 1.5 | 12.0 | GO:0006477 | protein sulfation(GO:0006477) |
| 1.5 | 7.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 1.5 | 4.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 1.5 | 16.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 1.5 | 8.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.5 | 4.4 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.5 | 4.4 | GO:0019376 | galactosylceramide catabolic process(GO:0006683) galactolipid catabolic process(GO:0019376) |
| 1.5 | 5.9 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 1.5 | 8.8 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 1.5 | 2.9 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 1.5 | 11.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 1.5 | 4.4 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
| 1.4 | 21.7 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 1.4 | 4.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 1.4 | 4.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 1.4 | 4.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.4 | 42.4 | GO:0060384 | innervation(GO:0060384) |
| 1.4 | 2.8 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 1.4 | 7.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 1.4 | 15.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 1.4 | 4.2 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
| 1.4 | 2.8 | GO:0031649 | heat generation(GO:0031649) |
| 1.4 | 2.8 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 1.4 | 47.2 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 1.4 | 5.5 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 1.4 | 4.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 1.4 | 5.5 | GO:0050957 | equilibrioception(GO:0050957) |
| 1.4 | 13.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 1.4 | 9.5 | GO:0022605 | ovarian cumulus expansion(GO:0001550) oogenesis stage(GO:0022605) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
| 1.4 | 8.2 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 1.4 | 5.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 1.4 | 8.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 1.4 | 5.4 | GO:0035936 | androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 1.3 | 10.8 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 1.3 | 6.7 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 1.3 | 6.7 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 1.3 | 6.7 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 1.3 | 8.0 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 1.3 | 9.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 1.3 | 17.3 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 1.3 | 4.0 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
| 1.3 | 4.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 1.3 | 6.6 | GO:0070166 | enamel mineralization(GO:0070166) |
| 1.3 | 5.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 1.3 | 2.6 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
| 1.3 | 3.9 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 1.3 | 3.9 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 1.3 | 5.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 1.3 | 7.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 1.3 | 3.9 | GO:0021586 | pons maturation(GO:0021586) |
| 1.3 | 11.8 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 1.3 | 7.8 | GO:0006569 | tryptophan catabolic process(GO:0006569) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
| 1.3 | 1.3 | GO:0006113 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 1.3 | 23.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 1.3 | 14.2 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 1.3 | 3.9 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 1.3 | 5.1 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 1.3 | 3.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 1.2 | 3.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 1.2 | 17.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 1.2 | 25.9 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 1.2 | 3.7 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 1.2 | 7.4 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 1.2 | 19.6 | GO:0032098 | regulation of appetite(GO:0032098) |
| 1.2 | 3.7 | GO:0035588 | purinergic receptor signaling pathway(GO:0035587) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
| 1.2 | 18.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 1.2 | 13.4 | GO:0048007 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 1.2 | 17.0 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 1.2 | 8.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 1.2 | 6.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 1.2 | 6.0 | GO:0015871 | choline transport(GO:0015871) |
| 1.2 | 13.2 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
| 1.2 | 4.8 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 1.2 | 6.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 1.2 | 3.6 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 1.2 | 2.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 1.2 | 15.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 1.2 | 3.6 | GO:0018343 | protein farnesylation(GO:0018343) |
| 1.2 | 15.4 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 1.2 | 3.5 | GO:0006562 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
| 1.2 | 16.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 1.2 | 3.5 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 1.2 | 3.5 | GO:1901374 | acetate ester transport(GO:1901374) |
| 1.2 | 11.7 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 1.2 | 10.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 1.2 | 18.6 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 1.2 | 6.9 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 1.2 | 4.6 | GO:0032900 | viral protein processing(GO:0019082) negative regulation of neurotrophin production(GO:0032900) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 1.1 | 8.0 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
| 1.1 | 5.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 1.1 | 22.7 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 1.1 | 7.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 1.1 | 11.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 1.1 | 5.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 1.1 | 5.7 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 1.1 | 4.5 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 1.1 | 3.4 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 1.1 | 2.3 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
| 1.1 | 5.6 | GO:0048243 | norepinephrine secretion(GO:0048243) |
| 1.1 | 3.4 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 1.1 | 2.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 1.1 | 4.4 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
| 1.1 | 3.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 1.1 | 13.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 1.1 | 2.2 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 1.1 | 17.5 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 1.1 | 5.4 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 1.1 | 8.7 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 1.1 | 7.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 1.1 | 5.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 1.1 | 6.5 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 1.1 | 4.3 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 1.1 | 9.6 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 1.1 | 5.3 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 1.1 | 10.6 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 1.1 | 7.4 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 1.1 | 7.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 1.1 | 2.1 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 1.1 | 11.7 | GO:0003094 | glomerular filtration(GO:0003094) |
| 1.1 | 2.1 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
| 1.1 | 3.2 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 1.1 | 5.3 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
| 1.0 | 3.1 | GO:0000050 | urea cycle(GO:0000050) |
| 1.0 | 3.1 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 1.0 | 104.1 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 1.0 | 3.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 1.0 | 3.1 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) glomerular visceral epithelial cell migration(GO:0090521) |
| 1.0 | 3.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 1.0 | 2.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 1.0 | 11.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 1.0 | 6.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 1.0 | 4.1 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 1.0 | 24.5 | GO:0007616 | long-term memory(GO:0007616) |
| 1.0 | 9.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 1.0 | 17.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 1.0 | 21.2 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 1.0 | 5.0 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 1.0 | 8.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 1.0 | 2.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 1.0 | 2.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 1.0 | 6.0 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 1.0 | 12.9 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 1.0 | 15.8 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
| 1.0 | 10.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 1.0 | 3.9 | GO:1904970 | brush border assembly(GO:1904970) |
| 1.0 | 5.9 | GO:0072540 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) T-helper 17 cell lineage commitment(GO:0072540) |
| 1.0 | 3.9 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 1.0 | 1.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 1.0 | 1.0 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
| 1.0 | 1.0 | GO:0038001 | paracrine signaling(GO:0038001) |
| 1.0 | 9.7 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 1.0 | 59.4 | GO:0006968 | cellular defense response(GO:0006968) |
| 1.0 | 3.8 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.9 | 1.9 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.9 | 1.9 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.9 | 4.7 | GO:0046618 | drug export(GO:0046618) |
| 0.9 | 2.8 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.9 | 5.6 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.9 | 2.8 | GO:0060032 | notochord regression(GO:0060032) |
| 0.9 | 0.9 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 0.9 | 8.4 | GO:0001825 | blastocyst formation(GO:0001825) |
| 0.9 | 4.6 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
| 0.9 | 4.6 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.9 | 2.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.9 | 4.6 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
| 0.9 | 11.9 | GO:0007530 | sex determination(GO:0007530) |
| 0.9 | 4.6 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.9 | 2.7 | GO:0046219 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
| 0.9 | 8.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 0.9 | 1.8 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.9 | 4.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.9 | 2.7 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.9 | 5.4 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
| 0.9 | 2.7 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.9 | 7.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.9 | 34.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.9 | 9.0 | GO:0046638 | positive regulation of alpha-beta T cell differentiation(GO:0046638) |
| 0.9 | 3.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.9 | 1.8 | GO:2000193 | positive regulation of icosanoid secretion(GO:0032305) positive regulation of fatty acid transport(GO:2000193) |
| 0.9 | 5.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.9 | 3.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.9 | 6.3 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.9 | 9.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.9 | 5.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.9 | 6.2 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
| 0.9 | 3.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.9 | 3.5 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
| 0.9 | 5.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.9 | 3.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.9 | 9.5 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
| 0.9 | 5.1 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.9 | 0.9 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.9 | 9.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.8 | 9.3 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.8 | 5.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.8 | 5.9 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.8 | 3.4 | GO:2000855 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.8 | 4.2 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.8 | 10.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.8 | 2.5 | GO:0042823 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.8 | 2.5 | GO:0001696 | gastric acid secretion(GO:0001696) |
| 0.8 | 18.1 | GO:0097503 | sialylation(GO:0097503) |
| 0.8 | 5.8 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.8 | 8.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.8 | 8.2 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.8 | 2.4 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 0.8 | 3.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.8 | 11.4 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.8 | 2.4 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.8 | 21.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.8 | 8.1 | GO:0006813 | potassium ion transport(GO:0006813) |
| 0.8 | 4.0 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.8 | 10.4 | GO:0042116 | macrophage activation(GO:0042116) |
| 0.8 | 4.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.8 | 4.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.8 | 4.0 | GO:1901091 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.8 | 12.7 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.8 | 2.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.8 | 3.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.8 | 4.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.8 | 6.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.8 | 10.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.8 | 2.3 | GO:0090285 | regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.8 | 1.5 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
| 0.8 | 6.9 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.8 | 6.9 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.8 | 8.4 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.8 | 13.7 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.8 | 4.6 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.8 | 2.3 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.8 | 1.5 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.8 | 2.3 | GO:1901874 | negative regulation of post-translational protein modification(GO:1901874) |
| 0.8 | 9.8 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.7 | 3.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.7 | 12.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.7 | 6.0 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.7 | 5.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.7 | 3.7 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.7 | 5.9 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
| 0.7 | 4.4 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.7 | 3.7 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.7 | 14.5 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.7 | 4.3 | GO:0019530 | taurine metabolic process(GO:0019530) |
| 0.7 | 13.0 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.7 | 1.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.7 | 6.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.7 | 5.7 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
| 0.7 | 3.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.7 | 2.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.7 | 12.1 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.7 | 4.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.7 | 5.0 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.7 | 4.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.7 | 19.8 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.7 | 8.5 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.7 | 6.4 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.7 | 7.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.7 | 10.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.7 | 11.1 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.7 | 65.7 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.7 | 2.1 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
| 0.7 | 4.8 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
| 0.7 | 3.4 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.7 | 3.4 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.7 | 6.2 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.7 | 3.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.7 | 8.2 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.7 | 1.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.7 | 3.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
| 0.7 | 4.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.7 | 8.8 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.7 | 4.0 | GO:0007602 | phototransduction(GO:0007602) |
| 0.7 | 8.7 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.7 | 0.7 | GO:1902603 | carnitine transmembrane transport(GO:1902603) |
| 0.7 | 3.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.7 | 2.0 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
| 0.7 | 7.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.7 | 2.7 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.7 | 4.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.7 | 3.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.6 | 2.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.6 | 4.5 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.6 | 3.9 | GO:0035766 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
| 0.6 | 10.3 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.6 | 5.1 | GO:0045651 | regulation of macrophage differentiation(GO:0045649) positive regulation of macrophage differentiation(GO:0045651) |
| 0.6 | 3.8 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.6 | 9.5 | GO:0070977 | bone maturation(GO:0070977) |
| 0.6 | 9.5 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.6 | 12.0 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.6 | 12.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.6 | 13.9 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.6 | 4.4 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.6 | 1.3 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.6 | 1.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.6 | 1.9 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.6 | 1.3 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
| 0.6 | 6.2 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.6 | 1.9 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
| 0.6 | 3.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.6 | 7.4 | GO:0032402 | melanosome transport(GO:0032402) |
| 0.6 | 1.2 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
| 0.6 | 1.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.6 | 4.9 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.6 | 23.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.6 | 21.3 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.6 | 4.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.6 | 14.0 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.6 | 14.6 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.6 | 1.8 | GO:0042441 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.6 | 1.8 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.6 | 2.4 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) regulation of rRNA processing(GO:2000232) |
| 0.6 | 3.6 | GO:0007320 | insemination(GO:0007320) |
| 0.6 | 6.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.6 | 5.9 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 0.6 | 3.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.6 | 7.7 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.6 | 1.2 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.6 | 4.7 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.6 | 4.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.6 | 5.8 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
| 0.6 | 2.3 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.6 | 2.3 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.6 | 4.6 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.6 | 2.9 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.6 | 2.8 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
| 0.6 | 10.8 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.6 | 1.7 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 0.6 | 1.1 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.6 | 4.5 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.6 | 3.9 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.6 | 9.5 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.6 | 0.6 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
| 0.6 | 8.9 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.6 | 2.2 | GO:0007210 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
| 0.6 | 2.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.6 | 17.7 | GO:0007140 | male meiosis(GO:0007140) |
| 0.6 | 2.2 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.6 | 1.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.6 | 2.8 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.5 | 1.6 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.5 | 10.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.5 | 1.6 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.5 | 3.8 | GO:0033561 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.5 | 8.6 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.5 | 19.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.5 | 3.7 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.5 | 2.6 | GO:0050868 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
| 0.5 | 4.2 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
| 0.5 | 8.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.5 | 2.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.5 | 7.7 | GO:0071621 | granulocyte chemotaxis(GO:0071621) |
| 0.5 | 12.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.5 | 5.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.5 | 4.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.5 | 3.0 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.5 | 1.5 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.5 | 6.0 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.5 | 3.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.5 | 2.5 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.5 | 4.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.5 | 7.3 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.5 | 4.3 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.5 | 1.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.5 | 2.4 | GO:0002517 | T cell tolerance induction(GO:0002517) |
| 0.5 | 15.5 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.5 | 2.8 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.5 | 4.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.5 | 1.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.5 | 1.9 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.5 | 1.8 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.5 | 6.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.5 | 4.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.5 | 0.5 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 0.5 | 14.0 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.4 | 5.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.4 | 2.2 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
| 0.4 | 10.6 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
| 0.4 | 2.2 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
| 0.4 | 12.7 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.4 | 18.2 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.4 | 3.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.4 | 27.2 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.4 | 16.4 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.4 | 5.1 | GO:0030828 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.4 | 2.6 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.4 | 3.8 | GO:0009650 | UV protection(GO:0009650) |
| 0.4 | 2.9 | GO:0021756 | striatum development(GO:0021756) |
| 0.4 | 3.7 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
| 0.4 | 1.2 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.4 | 9.8 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.4 | 4.5 | GO:0006833 | water transport(GO:0006833) |
| 0.4 | 3.3 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.4 | 5.3 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.4 | 6.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.4 | 1.2 | GO:0061081 | positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
| 0.4 | 2.7 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.4 | 7.3 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 0.4 | 10.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.4 | 3.0 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.4 | 4.5 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
| 0.4 | 1.1 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) establishment of meiotic spindle localization(GO:0051295) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.4 | 1.1 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.4 | 3.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.4 | 1.5 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
| 0.4 | 4.0 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
| 0.4 | 0.7 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.4 | 3.3 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.4 | 13.7 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.4 | 3.2 | GO:0072017 | distal tubule development(GO:0072017) |
| 0.4 | 6.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.3 | 1.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.3 | 1.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.3 | 1.4 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 0.3 | 1.0 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
| 0.3 | 2.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.3 | 3.0 | GO:0008356 | asymmetric cell division(GO:0008356) |
| 0.3 | 6.3 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.3 | 13.7 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.3 | 3.7 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.3 | 1.3 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.3 | 4.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.3 | 1.6 | GO:0032094 | response to food(GO:0032094) |
| 0.3 | 3.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.3 | 1.0 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.3 | 2.2 | GO:0001975 | response to amphetamine(GO:0001975) |
| 0.3 | 0.6 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.3 | 5.7 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.3 | 1.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.3 | 2.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.3 | 2.8 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.3 | 0.9 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
| 0.3 | 1.8 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.3 | 4.9 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.3 | 3.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.3 | 0.9 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.3 | 4.9 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
| 0.3 | 0.6 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.3 | 0.9 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 0.3 | 2.1 | GO:0043586 | tongue development(GO:0043586) |
| 0.3 | 2.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.3 | 3.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.3 | 11.6 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.3 | 0.9 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.3 | 2.8 | GO:0003341 | cilium movement(GO:0003341) |
| 0.3 | 1.4 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.3 | 0.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.3 | 0.6 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
| 0.3 | 5.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.3 | 3.0 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.3 | 6.3 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.3 | 0.3 | GO:1903961 | positive regulation of anion channel activity(GO:1901529) positive regulation of anion transmembrane transport(GO:1903961) |
| 0.3 | 0.8 | GO:0072337 | modified amino acid transport(GO:0072337) |
| 0.3 | 4.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.3 | 1.6 | GO:0030916 | otic vesicle formation(GO:0030916) otic vesicle morphogenesis(GO:0071600) |
| 0.3 | 1.0 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.3 | 5.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
| 0.3 | 0.5 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.3 | 2.0 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.3 | 5.0 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.3 | 2.3 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.2 | 2.2 | GO:0060073 | micturition(GO:0060073) |
| 0.2 | 3.9 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.2 | 2.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.2 | 4.2 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.2 | 2.7 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.2 | 0.7 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleoside transmembrane transport(GO:0015860) purine nucleobase transmembrane transport(GO:1904823) |
| 0.2 | 31.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.2 | 17.3 | GO:0007286 | spermatid development(GO:0007286) |
| 0.2 | 1.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 0.2 | 5.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.2 | 2.4 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.2 | 4.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.2 | 1.2 | GO:1901906 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.2 | 7.9 | GO:0061337 | cardiac conduction(GO:0061337) |
| 0.2 | 0.5 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.2 | 2.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.2 | 2.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.2 | 3.8 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.2 | 3.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.2 | 18.6 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.2 | 3.1 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.2 | 4.6 | GO:0090313 | regulation of protein targeting to membrane(GO:0090313) positive regulation of protein targeting to membrane(GO:0090314) |
| 0.2 | 0.6 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.2 | 1.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.2 | 0.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.2 | 1.0 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.2 | 15.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.2 | 2.2 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.2 | 0.8 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
| 0.2 | 0.8 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.2 | 0.6 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.2 | 0.8 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.2 | 8.9 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
| 0.2 | 0.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.2 | 3.4 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.2 | 0.8 | GO:0006549 | isoleucine metabolic process(GO:0006549) isoleucine catabolic process(GO:0006550) |
| 0.2 | 0.6 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.2 | 0.9 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.2 | 3.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.2 | 7.9 | GO:0007586 | digestion(GO:0007586) |
| 0.2 | 3.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.2 | 1.1 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 | 2.7 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.2 | 0.5 | GO:0048515 | spermatid differentiation(GO:0048515) |
| 0.2 | 1.0 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.2 | 0.5 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.2 | 3.4 | GO:0019054 | modulation by virus of host process(GO:0019054) |
| 0.2 | 12.4 | GO:0035108 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
| 0.2 | 3.3 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.2 | 1.3 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.2 | 0.3 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.2 | 1.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.2 | 1.7 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.2 | 0.6 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.2 | 1.6 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
| 0.2 | 1.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.1 | 1.5 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 1.0 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 1.0 | GO:0044849 | estrous cycle(GO:0044849) |
| 0.1 | 1.8 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
| 0.1 | 0.4 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.1 | 3.8 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
| 0.1 | 1.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.1 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
| 0.1 | 2.1 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.1 | 0.3 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.1 | 5.1 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
| 0.1 | 1.1 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.1 | 1.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.5 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.1 | 0.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 2.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 2.3 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 1.7 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
| 0.1 | 3.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.1 | 1.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 | 1.3 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 0.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.1 | 0.4 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.1 | 0.2 | GO:0036337 | Fas signaling pathway(GO:0036337) regulation of Fas signaling pathway(GO:1902044) |
| 0.1 | 1.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.1 | 2.1 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
| 0.1 | 0.3 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.1 | 5.0 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
| 0.1 | 0.5 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.1 | 0.8 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.1 | 8.5 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.1 | 1.3 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.1 | 1.3 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.1 | 1.2 | GO:1902656 | release of sequestered calcium ion into cytosol(GO:0051209) regulation of sequestering of calcium ion(GO:0051282) negative regulation of sequestering of calcium ion(GO:0051283) calcium ion transmembrane import into cytosol(GO:0097553) calcium ion import into cytosol(GO:1902656) |
| 0.1 | 0.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.1 | 2.9 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
| 0.1 | 1.9 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.1 | 0.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 0.7 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.1 | 4.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
| 0.1 | 0.7 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.1 | 0.5 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.1 | 0.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.0 | 0.8 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.0 | 0.2 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.0 | 0.4 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.0 | 0.4 | GO:0035909 | aorta morphogenesis(GO:0035909) |
| 0.0 | 0.5 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.0 | 0.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of autophagosome maturation(GO:1901097) |
| 0.0 | 0.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.0 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 | 0.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 | 0.1 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
| 0.0 | 0.0 | GO:0071871 | response to epinephrine(GO:0071871) cellular response to epinephrine stimulus(GO:0071872) |
| 0.0 | 0.2 | GO:0003322 | pancreatic A cell differentiation(GO:0003310) pancreatic A cell development(GO:0003322) |
| 0.0 | 0.0 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 16.1 | 64.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 15.0 | 45.1 | GO:0071753 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
| 11.1 | 553.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 8.4 | 50.4 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 7.5 | 30.0 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 6.5 | 19.4 | GO:0097679 | other organism cytoplasm(GO:0097679) |
| 6.5 | 6.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 6.4 | 122.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 6.2 | 37.4 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 5.9 | 11.8 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 5.7 | 74.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 5.7 | 63.0 | GO:0043203 | axon hillock(GO:0043203) |
| 5.6 | 72.7 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 5.6 | 27.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 5.5 | 87.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 5.4 | 107.1 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 5.3 | 47.8 | GO:0032010 | phagolysosome(GO:0032010) |
| 5.2 | 15.6 | GO:0070701 | mucus layer(GO:0070701) |
| 5.2 | 15.5 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 5.1 | 51.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 5.1 | 15.3 | GO:0098536 | deuterosome(GO:0098536) |
| 4.9 | 14.8 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 4.7 | 23.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 4.7 | 14.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 4.5 | 35.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 4.4 | 17.8 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 4.4 | 17.6 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 4.4 | 17.4 | GO:0000801 | central element(GO:0000801) |
| 4.2 | 12.6 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 4.2 | 8.4 | GO:0097183 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 3.9 | 30.9 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 3.8 | 18.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 3.7 | 32.9 | GO:0033391 | chromatoid body(GO:0033391) |
| 3.6 | 32.4 | GO:0070652 | HAUS complex(GO:0070652) |
| 3.6 | 10.7 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 3.5 | 17.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 3.1 | 12.4 | GO:0070695 | FHF complex(GO:0070695) |
| 3.1 | 18.3 | GO:0033269 | internode region of axon(GO:0033269) |
| 3.0 | 9.0 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 2.9 | 2.9 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 2.9 | 446.6 | GO:0072562 | blood microparticle(GO:0072562) |
| 2.9 | 20.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 2.9 | 23.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 2.9 | 37.7 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 2.9 | 43.1 | GO:0033270 | paranode region of axon(GO:0033270) |
| 2.9 | 17.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 2.8 | 8.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 2.7 | 8.2 | GO:0034657 | GID complex(GO:0034657) |
| 2.7 | 49.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 2.7 | 27.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 2.7 | 16.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 2.7 | 43.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 2.6 | 28.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 2.6 | 88.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 2.5 | 7.5 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 2.5 | 37.6 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 2.5 | 7.5 | GO:0048788 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
| 2.5 | 62.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 2.5 | 14.8 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 2.5 | 12.3 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
| 2.4 | 2.4 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 2.4 | 24.4 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 2.4 | 68.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 2.3 | 16.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
| 2.3 | 4.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 2.2 | 55.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 2.2 | 8.7 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 2.1 | 100.4 | GO:0001533 | cornified envelope(GO:0001533) |
| 2.1 | 10.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 2.1 | 20.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 2.0 | 8.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 2.0 | 9.9 | GO:0072534 | perineuronal net(GO:0072534) |
| 1.9 | 9.7 | GO:0036398 | TCR signalosome(GO:0036398) |
| 1.9 | 17.4 | GO:0071953 | elastic fiber(GO:0071953) |
| 1.9 | 9.5 | GO:0070847 | core mediator complex(GO:0070847) |
| 1.9 | 27.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 1.9 | 7.4 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 1.8 | 22.1 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 1.8 | 23.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 1.8 | 5.4 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 1.8 | 7.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 1.8 | 3.5 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 1.7 | 8.7 | GO:0045179 | apical cortex(GO:0045179) |
| 1.7 | 8.4 | GO:0089701 | U2AF(GO:0089701) |
| 1.7 | 3.3 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 1.7 | 10.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 1.7 | 24.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 1.6 | 17.6 | GO:0005955 | calcineurin complex(GO:0005955) |
| 1.6 | 9.5 | GO:0045298 | tubulin complex(GO:0045298) |
| 1.6 | 7.9 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 1.5 | 7.6 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 1.5 | 6.0 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 1.5 | 9.1 | GO:0044194 | cytolytic granule(GO:0044194) |
| 1.5 | 13.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 1.5 | 22.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 1.5 | 17.7 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 1.5 | 7.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 1.5 | 24.7 | GO:0005861 | troponin complex(GO:0005861) |
| 1.4 | 24.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 1.4 | 7.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 1.4 | 5.7 | GO:0035363 | histone locus body(GO:0035363) |
| 1.4 | 2.8 | GO:0032797 | SMN complex(GO:0032797) |
| 1.4 | 4.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 1.4 | 12.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 1.3 | 5.4 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 1.3 | 22.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 1.3 | 5.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 1.3 | 8.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 1.3 | 14.6 | GO:0043194 | axon initial segment(GO:0043194) |
| 1.3 | 24.8 | GO:0036038 | MKS complex(GO:0036038) |
| 1.3 | 144.6 | GO:0005796 | Golgi lumen(GO:0005796) |
| 1.3 | 8.9 | GO:0043196 | varicosity(GO:0043196) |
| 1.3 | 17.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 1.3 | 2.5 | GO:0071546 | pi-body(GO:0071546) |
| 1.2 | 10.0 | GO:0097433 | dense body(GO:0097433) |
| 1.2 | 10.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 1.2 | 92.6 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 1.2 | 8.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 1.2 | 14.7 | GO:0097427 | microtubule bundle(GO:0097427) |
| 1.2 | 7.2 | GO:0070545 | PeBoW complex(GO:0070545) |
| 1.2 | 4.7 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 1.2 | 25.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 1.1 | 8.0 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 1.1 | 2.3 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 1.1 | 72.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 1.1 | 3.4 | GO:0030312 | external encapsulating structure(GO:0030312) |
| 1.1 | 4.5 | GO:0048179 | activin receptor complex(GO:0048179) |
| 1.1 | 6.7 | GO:0071437 | invadopodium(GO:0071437) |
| 1.1 | 3.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
| 1.1 | 15.2 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
| 1.0 | 5.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 1.0 | 4.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 1.0 | 5.2 | GO:0031905 | early endosome lumen(GO:0031905) |
| 1.0 | 2.0 | GO:0031906 | late endosome lumen(GO:0031906) |
| 1.0 | 4.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 1.0 | 4.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 1.0 | 4.1 | GO:0032584 | growth cone membrane(GO:0032584) |
| 1.0 | 1.0 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 1.0 | 4.0 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 1.0 | 5.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 1.0 | 6.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 1.0 | 3.9 | GO:0060091 | kinocilium(GO:0060091) |
| 1.0 | 150.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 1.0 | 57.7 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 1.0 | 13.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 1.0 | 78.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 1.0 | 4.8 | GO:0005579 | membrane attack complex(GO:0005579) |
| 1.0 | 6.7 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.9 | 9.4 | GO:0098644 | complex of collagen trimers(GO:0098644) |
| 0.9 | 5.6 | GO:0002177 | manchette(GO:0002177) |
| 0.9 | 18.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.9 | 8.4 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.9 | 6.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.9 | 19.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.9 | 3.6 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.9 | 18.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.9 | 8.9 | GO:0005883 | neurofilament(GO:0005883) |
| 0.9 | 12.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.9 | 3.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.9 | 16.0 | GO:0005922 | connexon complex(GO:0005922) |
| 0.9 | 20.4 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.9 | 87.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.9 | 62.3 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.8 | 14.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.8 | 9.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.8 | 5.0 | GO:0032009 | early phagosome(GO:0032009) |
| 0.8 | 3.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.8 | 4.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.8 | 10.6 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.8 | 3.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.8 | 4.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.8 | 4.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.8 | 8.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.8 | 8.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.8 | 113.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.8 | 1037.8 | GO:0005615 | extracellular space(GO:0005615) |
| 0.8 | 14.6 | GO:0016342 | catenin complex(GO:0016342) |
| 0.8 | 11.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.7 | 4.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.7 | 5.0 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.7 | 25.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.7 | 31.9 | GO:0005902 | microvillus(GO:0005902) |
| 0.7 | 8.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.7 | 8.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.7 | 4.9 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.7 | 17.0 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.7 | 19.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.7 | 2.7 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.7 | 55.1 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.6 | 9.1 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.6 | 27.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.6 | 1.9 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.6 | 26.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.6 | 2.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.6 | 1.8 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.6 | 8.8 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.6 | 1.7 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.6 | 10.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.5 | 5.4 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.5 | 8.7 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.5 | 3.2 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.5 | 5.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.5 | 3.7 | GO:1990745 | EARP complex(GO:1990745) |
| 0.5 | 4.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.5 | 5.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.5 | 1.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.5 | 5.1 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.5 | 4.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.5 | 0.9 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.4 | 7.0 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.4 | 4.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.4 | 5.7 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.4 | 11.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.4 | 2.5 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.4 | 9.1 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.4 | 1.2 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.4 | 2.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.4 | 6.7 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.4 | 14.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.4 | 1.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.4 | 1.5 | GO:1990879 | CST complex(GO:1990879) |
| 0.4 | 6.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.4 | 537.4 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
| 0.4 | 16.7 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.3 | 6.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.3 | 4.3 | GO:0042555 | MCM complex(GO:0042555) |
| 0.3 | 2.8 | GO:0044292 | dendrite terminus(GO:0044292) dendritic growth cone(GO:0044294) |
| 0.3 | 1.9 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.3 | 1.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.3 | 7.9 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.3 | 3.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
| 0.3 | 8.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.3 | 6.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.3 | 2.0 | GO:0044447 | axoneme part(GO:0044447) |
| 0.3 | 2.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.3 | 1.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.3 | 1.8 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.3 | 8.5 | GO:0016592 | mediator complex(GO:0016592) |
| 0.3 | 1.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.2 | 9.8 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.2 | 3.7 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.2 | 10.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.2 | 8.9 | GO:0005604 | basement membrane(GO:0005604) |
| 0.2 | 510.5 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
| 0.1 | 1.7 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.1 | 2.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 1.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.1 | 1.6 | GO:0000800 | lateral element(GO:0000800) |
| 0.1 | 0.4 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.1 | 0.9 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 3.7 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.1 | 1.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 0.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.1 | 1.1 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.1 | 0.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.1 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 1.3 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
| 0.1 | 9.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.1 | 0.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.0 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.0 | 0.1 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) spindle pole body(GO:0005816) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.7 | 63.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 11.5 | 80.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 9.9 | 49.7 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 9.6 | 38.4 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 9.5 | 569.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 8.5 | 25.4 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
| 8.4 | 33.5 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 7.8 | 38.9 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 7.6 | 91.3 | GO:0008430 | selenium binding(GO:0008430) |
| 7.5 | 22.6 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 7.3 | 29.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 7.3 | 87.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 6.9 | 20.8 | GO:0036055 | protein-malonyllysine demalonylase activity(GO:0036054) protein-succinyllysine desuccinylase activity(GO:0036055) protein-glutaryllysine deglutarylase activity(GO:0061697) |
| 6.9 | 6.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 6.7 | 40.4 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
| 6.7 | 20.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 6.6 | 19.9 | GO:0033746 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
| 6.4 | 76.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 6.3 | 18.8 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
| 5.9 | 29.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 5.7 | 51.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 5.7 | 79.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 5.4 | 16.2 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 5.4 | 21.5 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 5.3 | 37.4 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 5.3 | 5.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 5.2 | 42.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 5.2 | 15.7 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 5.1 | 45.9 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 4.9 | 19.6 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 4.9 | 44.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 4.9 | 14.6 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 4.9 | 34.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 4.8 | 14.3 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 4.7 | 42.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 4.7 | 14.0 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 4.7 | 18.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 4.7 | 14.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 4.6 | 18.5 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 4.6 | 13.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 4.6 | 23.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 4.6 | 18.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 4.6 | 18.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 4.5 | 4.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 4.5 | 13.4 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 4.5 | 13.4 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 4.5 | 31.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 4.4 | 31.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 4.4 | 17.4 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 4.3 | 761.9 | GO:0003823 | antigen binding(GO:0003823) |
| 4.2 | 55.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 4.2 | 21.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 4.2 | 12.6 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 4.1 | 20.7 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 4.1 | 12.4 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 4.1 | 16.5 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 4.1 | 37.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 4.0 | 20.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 4.0 | 11.9 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 3.9 | 11.8 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 3.9 | 23.6 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 3.9 | 11.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 3.9 | 11.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 3.9 | 30.9 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 3.8 | 23.1 | GO:0004359 | glutaminase activity(GO:0004359) |
| 3.8 | 26.6 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 3.8 | 18.9 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 3.7 | 18.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 3.7 | 7.5 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 3.7 | 18.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 3.7 | 3.7 | GO:0047787 | enone reductase activity(GO:0035671) delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
| 3.6 | 68.3 | GO:0038191 | neuropilin binding(GO:0038191) |
| 3.6 | 42.8 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 3.6 | 7.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 3.5 | 10.6 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 3.5 | 17.6 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 3.5 | 14.1 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 3.5 | 10.5 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 3.5 | 20.8 | GO:0030172 | troponin C binding(GO:0030172) |
| 3.4 | 17.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 3.4 | 20.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 3.4 | 101.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 3.4 | 10.1 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 3.3 | 16.7 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 3.3 | 10.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 3.3 | 16.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 3.3 | 16.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 3.2 | 9.7 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 3.2 | 12.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 3.2 | 16.0 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 3.2 | 6.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 3.2 | 9.6 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 3.1 | 25.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 3.1 | 15.5 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 3.1 | 18.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 3.0 | 6.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 3.0 | 9.1 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
| 3.0 | 12.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 3.0 | 9.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 3.0 | 21.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 3.0 | 15.0 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 3.0 | 11.8 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 2.9 | 8.8 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 2.9 | 8.8 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 2.9 | 14.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 2.9 | 14.4 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 2.9 | 11.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 2.9 | 51.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 2.8 | 17.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 2.8 | 19.8 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 2.8 | 14.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 2.8 | 11.3 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
| 2.8 | 14.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 2.8 | 11.2 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 2.8 | 8.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 2.7 | 19.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 2.7 | 16.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 2.7 | 8.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 2.7 | 8.1 | GO:0070052 | collagen V binding(GO:0070052) |
| 2.7 | 5.4 | GO:0035473 | lipase binding(GO:0035473) |
| 2.7 | 2.7 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 2.7 | 8.0 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 2.7 | 16.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 2.7 | 15.9 | GO:0051373 | FATZ binding(GO:0051373) |
| 2.6 | 23.8 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 2.6 | 15.8 | GO:0004875 | complement receptor activity(GO:0004875) |
| 2.6 | 29.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 2.6 | 7.9 | GO:0017129 | triglyceride binding(GO:0017129) |
| 2.6 | 76.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 2.6 | 15.7 | GO:0031014 | troponin T binding(GO:0031014) |
| 2.6 | 7.8 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 2.6 | 23.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 2.6 | 25.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 2.5 | 15.2 | GO:0051430 | mu-type opioid receptor binding(GO:0031852) corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 2.5 | 22.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 2.5 | 7.5 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 2.5 | 10.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 2.5 | 22.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 2.5 | 2.5 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 2.5 | 7.5 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 2.5 | 5.0 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 2.5 | 4.9 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 2.5 | 4.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 2.5 | 7.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 2.5 | 32.0 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
| 2.5 | 7.4 | GO:0052816 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
| 2.4 | 12.2 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 2.4 | 7.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 2.4 | 41.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 2.4 | 9.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 2.4 | 16.7 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 2.4 | 9.5 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 2.4 | 7.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 2.4 | 14.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 2.4 | 68.9 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 2.4 | 7.1 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 2.3 | 9.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 2.3 | 30.3 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 2.3 | 16.2 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 2.3 | 11.5 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 2.3 | 6.8 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 2.3 | 13.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 2.3 | 11.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 2.3 | 11.3 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 2.2 | 4.5 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 2.2 | 20.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 2.2 | 33.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 2.2 | 31.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 2.2 | 13.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 2.2 | 6.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 2.2 | 17.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 2.2 | 6.6 | GO:0031711 | angiotensin type I receptor activity(GO:0001596) bradykinin receptor binding(GO:0031711) |
| 2.2 | 8.7 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 2.2 | 13.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 2.2 | 21.7 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 2.2 | 23.8 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
| 2.2 | 13.0 | GO:0003796 | lysozyme activity(GO:0003796) |
| 2.2 | 2.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 2.1 | 17.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 2.1 | 10.7 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
| 2.1 | 12.8 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 2.1 | 10.7 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 2.1 | 21.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 2.1 | 10.6 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 2.1 | 21.3 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 2.1 | 10.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 2.1 | 8.4 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 2.1 | 8.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 2.1 | 226.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 2.1 | 4.2 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 2.1 | 8.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 2.1 | 20.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 2.0 | 8.2 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
| 2.0 | 6.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 2.0 | 14.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 2.0 | 22.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 2.0 | 53.6 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
| 2.0 | 25.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 2.0 | 17.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 2.0 | 25.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 2.0 | 11.9 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 2.0 | 13.8 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 2.0 | 13.8 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 2.0 | 3.9 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 1.9 | 13.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 1.9 | 9.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 1.9 | 5.8 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) Toll-like receptor 2 binding(GO:0035663) |
| 1.9 | 5.8 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 1.9 | 7.7 | GO:1904493 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
| 1.9 | 19.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 1.9 | 30.6 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
| 1.9 | 5.7 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 1.9 | 22.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 1.9 | 7.4 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 1.8 | 42.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 1.8 | 5.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 1.8 | 5.5 | GO:0004040 | amidase activity(GO:0004040) |
| 1.8 | 5.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 1.8 | 12.7 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 1.8 | 5.4 | GO:0008431 | vitamin E binding(GO:0008431) |
| 1.8 | 5.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 1.8 | 8.9 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 1.8 | 7.1 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 1.8 | 30.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 1.8 | 394.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 1.8 | 15.8 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 1.7 | 8.7 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 1.7 | 7.0 | GO:0035586 | purinergic receptor activity(GO:0035586) |
| 1.7 | 3.5 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 1.7 | 20.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 1.7 | 13.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 1.7 | 25.6 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 1.7 | 8.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 1.7 | 3.4 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 1.7 | 6.8 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 1.7 | 15.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 1.7 | 11.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 1.7 | 13.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 1.7 | 39.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 1.7 | 10.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 1.7 | 16.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 1.7 | 6.6 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 1.6 | 37.7 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 1.6 | 4.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 1.6 | 6.5 | GO:0004079 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
| 1.6 | 19.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 1.6 | 4.8 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 1.6 | 33.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 1.6 | 9.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
| 1.6 | 4.8 | GO:0016154 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 1.6 | 39.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 1.6 | 15.9 | GO:0005549 | odorant binding(GO:0005549) |
| 1.5 | 12.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 1.5 | 46.0 | GO:0008009 | chemokine activity(GO:0008009) |
| 1.5 | 16.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 1.5 | 4.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 1.5 | 6.1 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 1.5 | 6.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 1.5 | 6.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 1.5 | 10.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 1.5 | 10.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 1.5 | 4.4 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
| 1.5 | 16.2 | GO:0019864 | IgG binding(GO:0019864) |
| 1.5 | 5.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 1.5 | 13.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 1.5 | 7.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 1.4 | 20.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 1.4 | 53.3 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
| 1.4 | 4.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 1.4 | 5.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 1.4 | 1.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
| 1.4 | 5.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 1.4 | 5.7 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 1.4 | 12.7 | GO:0043426 | MRF binding(GO:0043426) |
| 1.4 | 8.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 1.4 | 8.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 1.4 | 4.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 1.4 | 18.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 1.4 | 16.7 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 1.4 | 5.5 | GO:0016793 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
| 1.4 | 5.5 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 1.4 | 11.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 1.4 | 26.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 1.4 | 20.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 1.3 | 10.8 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 1.3 | 9.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 1.3 | 2.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 1.3 | 21.4 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
| 1.3 | 19.9 | GO:0015923 | mannosidase activity(GO:0015923) |
| 1.3 | 3.9 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 1.3 | 34.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 1.3 | 2.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
| 1.3 | 16.8 | GO:0016918 | retinal binding(GO:0016918) |
| 1.3 | 19.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 1.3 | 6.5 | GO:0030955 | potassium ion binding(GO:0030955) |
| 1.3 | 14.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 1.3 | 11.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 1.3 | 6.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 1.3 | 3.8 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 1.3 | 8.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 1.3 | 8.9 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 1.3 | 3.8 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 1.3 | 3.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 1.3 | 50.4 | GO:0015026 | coreceptor activity(GO:0015026) |
| 1.3 | 7.5 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 1.2 | 17.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 1.2 | 3.7 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 1.2 | 4.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 1.2 | 3.7 | GO:0004938 | alpha-adrenergic receptor activity(GO:0004936) alpha2-adrenergic receptor activity(GO:0004938) |
| 1.2 | 13.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 1.2 | 13.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 1.2 | 3.6 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
| 1.2 | 28.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 1.2 | 4.7 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 1.2 | 14.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 1.2 | 8.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 1.2 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 1.2 | 18.7 | GO:0000150 | recombinase activity(GO:0000150) |
| 1.2 | 36.2 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 1.2 | 9.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 1.2 | 10.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 1.2 | 3.5 | GO:0070984 | SET domain binding(GO:0070984) |
| 1.2 | 15.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 1.1 | 4.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 1.1 | 3.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 1.1 | 9.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 1.1 | 26.0 | GO:0031402 | sodium ion binding(GO:0031402) |
| 1.1 | 6.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 1.1 | 9.0 | GO:0015643 | toxic substance binding(GO:0015643) |
| 1.1 | 10.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 1.1 | 5.6 | GO:0050610 | glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 1.1 | 16.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 1.1 | 1.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 1.1 | 4.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 1.1 | 13.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 1.1 | 2.2 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 1.1 | 66.2 | GO:0030507 | spectrin binding(GO:0030507) |
| 1.1 | 56.0 | GO:0005254 | chloride channel activity(GO:0005254) |
| 1.1 | 9.7 | GO:0070679 | store-operated calcium channel activity(GO:0015279) inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 1.1 | 5.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 1.1 | 4.3 | GO:0045569 | TRAIL binding(GO:0045569) |
| 1.1 | 7.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 1.1 | 24.5 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 1.1 | 10.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 1.1 | 10.5 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 1.0 | 6.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
| 1.0 | 9.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
| 1.0 | 2.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 1.0 | 4.1 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 1.0 | 6.2 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 1.0 | 14.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 1.0 | 18.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 1.0 | 2.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 1.0 | 4.0 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 1.0 | 26.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 1.0 | 4.0 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 1.0 | 10.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 1.0 | 3.9 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 1.0 | 5.9 | GO:0070728 | leucine binding(GO:0070728) |
| 1.0 | 3.9 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 1.0 | 3.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 1.0 | 7.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 1.0 | 54.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 1.0 | 5.8 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 1.0 | 4.8 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 1.0 | 12.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 1.0 | 4.8 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 1.0 | 13.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 1.0 | 6.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.9 | 3.8 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.9 | 1.9 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.9 | 3.8 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.9 | 2.8 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
| 0.9 | 5.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.9 | 87.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.9 | 5.6 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.9 | 2.8 | GO:0051379 | beta-adrenergic receptor activity(GO:0004939) epinephrine binding(GO:0051379) norepinephrine binding(GO:0051380) |
| 0.9 | 12.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.9 | 19.5 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.9 | 4.6 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.9 | 6.5 | GO:0001221 | transcription cofactor binding(GO:0001221) transcription corepressor binding(GO:0001222) |
| 0.9 | 6.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.9 | 19.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.9 | 6.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.9 | 12.7 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.9 | 3.6 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.9 | 5.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 0.9 | 2.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.9 | 13.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.9 | 4.5 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.9 | 13.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.9 | 2.7 | GO:0031432 | titin binding(GO:0031432) |
| 0.9 | 5.3 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.9 | 6.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.9 | 8.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.9 | 12.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.9 | 9.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.9 | 3.4 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.9 | 12.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.9 | 3.4 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.9 | 17.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.8 | 4.2 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.8 | 5.9 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 0.8 | 4.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.8 | 14.9 | GO:0070513 | death domain binding(GO:0070513) |
| 0.8 | 15.7 | GO:0016595 | glutamate binding(GO:0016595) |
| 0.8 | 2.4 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
| 0.8 | 5.7 | GO:0005497 | androgen binding(GO:0005497) |
| 0.8 | 6.3 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.8 | 7.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.8 | 6.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.8 | 8.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.8 | 18.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.8 | 2.3 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.8 | 6.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.8 | 2.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.8 | 25.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.8 | 21.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.8 | 3.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.8 | 55.7 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.8 | 9.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.7 | 8.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.7 | 0.7 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.7 | 5.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.7 | 5.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.7 | 9.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.7 | 14.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.7 | 12.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.7 | 2.1 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.7 | 9.9 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
| 0.7 | 5.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.7 | 1.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.7 | 9.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.7 | 17.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.7 | 11.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.7 | 51.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.7 | 8.9 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.7 | 2.7 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.7 | 1.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.7 | 6.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.7 | 27.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.7 | 3.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.7 | 18.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.7 | 22.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.7 | 4.6 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.6 | 1.9 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.6 | 7.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.6 | 5.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.6 | 8.1 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.6 | 3.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.6 | 22.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.6 | 1.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.6 | 2.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.6 | 3.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.6 | 6.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.6 | 3.6 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.6 | 4.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.6 | 2.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.6 | 1.7 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.6 | 3.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.6 | 1.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.6 | 8.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.6 | 2.8 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.6 | 12.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.6 | 3.4 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.6 | 2.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 0.6 | 3.9 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.6 | 4.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.6 | 8.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.6 | 4.4 | GO:0038024 | cargo receptor activity(GO:0038024) |
| 0.5 | 12.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.5 | 2.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.5 | 2.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.5 | 20.2 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
| 0.5 | 2.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.5 | 5.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.5 | 4.7 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
| 0.5 | 2.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.5 | 5.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
| 0.5 | 1.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.5 | 2.0 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.5 | 14.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.5 | 1.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.5 | 3.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.5 | 10.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.5 | 1.9 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
| 0.5 | 2.9 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.5 | 5.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.5 | 6.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
| 0.5 | 7.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.5 | 2.3 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.5 | 1.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.4 | 1.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.4 | 2.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.4 | 7.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.4 | 2.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.4 | 1.3 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.4 | 6.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.4 | 25.0 | GO:0004497 | monooxygenase activity(GO:0004497) |
| 0.4 | 3.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.4 | 13.6 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.4 | 1.3 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.4 | 3.4 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.4 | 4.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.4 | 1.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.4 | 1.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 0.4 | 3.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.4 | 6.6 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.4 | 2.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.4 | 20.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.4 | 3.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.4 | 2.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.4 | 3.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.4 | 1.6 | GO:0002046 | opsin binding(GO:0002046) |
| 0.4 | 10.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.4 | 1.2 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.4 | 2.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.4 | 11.9 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.4 | 2.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.4 | 1.5 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.4 | 6.2 | GO:0031005 | filamin binding(GO:0031005) |
| 0.4 | 1.8 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.4 | 29.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.4 | 2.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.4 | 3.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.4 | 0.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.3 | 12.9 | GO:0043621 | protein self-association(GO:0043621) |
| 0.3 | 59.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.3 | 8.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.3 | 0.7 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.3 | 3.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.3 | 51.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.3 | 19.9 | GO:0005179 | hormone activity(GO:0005179) |
| 0.3 | 5.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.3 | 8.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.3 | 2.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.3 | 6.0 | GO:0015108 | chloride transmembrane transporter activity(GO:0015108) |
| 0.3 | 4.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.3 | 1.2 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.3 | 1.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.3 | 0.9 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
| 0.3 | 6.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.3 | 3.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.3 | 27.7 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.3 | 31.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.3 | 3.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.3 | 4.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.3 | 0.8 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.3 | 4.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.3 | 12.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.3 | 3.3 | GO:0005112 | Notch binding(GO:0005112) |
| 0.3 | 1.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.3 | 2.9 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.3 | 1.0 | GO:0019863 | IgE binding(GO:0019863) |
| 0.3 | 308.4 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.2 | 1.0 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.2 | 2.2 | GO:0099589 | serotonin receptor activity(GO:0099589) |
| 0.2 | 9.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.2 | 0.7 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 0.2 | 5.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.2 | 0.7 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.2 | 1.2 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.2 | 5.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.2 | 2.5 | GO:0010181 | FMN binding(GO:0010181) |
| 0.2 | 18.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.2 | 13.9 | GO:0005261 | cation channel activity(GO:0005261) |
| 0.2 | 3.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.2 | 3.4 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 0.2 | 0.9 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.2 | 4.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.2 | 22.4 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
| 0.2 | 2.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.2 | 3.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.2 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.2 | 2.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.2 | 0.7 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.2 | 3.6 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
| 0.2 | 2.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.2 | 1.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.2 | 1.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.2 | 2.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 1.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.2 | 2.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.2 | 11.2 | GO:0008201 | heparin binding(GO:0008201) |
| 0.2 | 0.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
| 0.2 | 0.9 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.2 | 0.8 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.2 | 0.5 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.1 | 1.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.1 | 1.0 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.1 | 2.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 3.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
| 0.1 | 15.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.1 | 1.6 | GO:0042805 | actinin binding(GO:0042805) |
| 0.1 | 0.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.1 | 1.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 3.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.1 | 1.3 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.1 | 4.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.1 | 1.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 0.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 0.2 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
| 0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.1 | 2.0 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.1 | 0.9 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.1 | 15.1 | GO:0004888 | transmembrane signaling receptor activity(GO:0004888) |
| 0.0 | 0.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 0.2 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.0 | 0.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.0 | 0.1 | GO:0005109 | frizzled binding(GO:0005109) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.1 | 15.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 2.7 | 131.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 2.4 | 52.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 2.3 | 2.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 2.1 | 8.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 2.1 | 4.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 1.9 | 15.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 1.9 | 14.8 | PID ALK1 PATHWAY | ALK1 signaling events |
| 1.8 | 61.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 1.6 | 26.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 1.6 | 9.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 1.6 | 12.7 | ST STAT3 PATHWAY | STAT3 Pathway |
| 1.5 | 10.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 1.5 | 109.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 1.4 | 83.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 1.4 | 8.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 1.4 | 18.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 1.3 | 25.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 1.2 | 48.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 1.2 | 25.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 1.2 | 21.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 1.2 | 214.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 1.2 | 64.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 1.2 | 5.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 1.2 | 59.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 1.1 | 112.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 1.1 | 21.4 | PID EPO PATHWAY | EPO signaling pathway |
| 1.1 | 48.6 | NABA COLLAGENS | Genes encoding collagen proteins |
| 1.1 | 36.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 1.1 | 10.9 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 1.0 | 27.0 | ST GAQ PATHWAY | G alpha q Pathway |
| 1.0 | 20.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 1.0 | 5.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 1.0 | 24.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 1.0 | 3.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 1.0 | 257.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 1.0 | 5.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.9 | 7.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.9 | 16.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.8 | 6.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.8 | 7.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.8 | 16.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.8 | 10.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.8 | 51.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.8 | 14.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.8 | 17.3 | ST ADRENERGIC | Adrenergic Pathway |
| 0.7 | 10.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.7 | 10.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.7 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.7 | 5.6 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.7 | 4.8 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.7 | 20.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.7 | 34.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.7 | 6.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.7 | 40.5 | PID BMP PATHWAY | BMP receptor signaling |
| 0.6 | 41.9 | PID FGF PATHWAY | FGF signaling pathway |
| 0.6 | 29.0 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.6 | 2.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.6 | 7.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.6 | 15.1 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.6 | 2.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.5 | 25.8 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.5 | 4.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.5 | 10.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.5 | 4.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.5 | 13.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.5 | 9.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.5 | 8.3 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.5 | 10.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.5 | 91.0 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
| 0.4 | 13.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.4 | 5.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.4 | 2.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.4 | 135.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.4 | 5.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.4 | 5.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.4 | 1.1 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.4 | 2.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.4 | 37.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.4 | 4.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.4 | 5.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.3 | 14.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.3 | 4.6 | PID MYC PATHWAY | C-MYC pathway |
| 0.3 | 8.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.3 | 10.2 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.3 | 3.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.2 | 3.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.2 | 12.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 5.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.2 | 3.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.2 | 7.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.2 | 5.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.2 | 3.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.2 | 3.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.2 | 12.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.2 | 2.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.2 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.1 | 12.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.1 | 4.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 3.6 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 2.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 1.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.1 | 3.9 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 0.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 0.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.0 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.4 | 8.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 6.4 | 12.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 5.4 | 10.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 5.3 | 5.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 4.1 | 87.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 4.1 | 78.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 4.1 | 74.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 4.1 | 73.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 3.8 | 3.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 3.7 | 3.7 | REACTOME INNATE IMMUNE SYSTEM | Genes involved in Innate Immune System |
| 3.4 | 6.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 3.2 | 9.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 3.2 | 54.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 3.2 | 51.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 3.1 | 64.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 3.0 | 12.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 2.8 | 36.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 2.6 | 2.6 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 2.6 | 35.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 2.5 | 15.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 2.5 | 27.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 2.3 | 29.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 2.2 | 52.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 2.1 | 6.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 2.0 | 43.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 2.0 | 43.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 1.9 | 169.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 1.9 | 124.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 1.9 | 50.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 1.8 | 46.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 1.7 | 74.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 1.7 | 17.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 1.7 | 30.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 1.6 | 27.9 | REACTOME DEFENSINS | Genes involved in Defensins |
| 1.6 | 67.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 1.6 | 12.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 1.6 | 6.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 1.6 | 12.6 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 1.5 | 9.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 1.4 | 83.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 1.4 | 20.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 1.3 | 17.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 1.3 | 42.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 1.3 | 47.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 1.3 | 48.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 1.2 | 24.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 1.2 | 57.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 1.2 | 19.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 1.2 | 11.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 1.2 | 14.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 1.2 | 4.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 1.2 | 36.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 1.2 | 18.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 1.2 | 5.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 1.1 | 150.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 1.1 | 4.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 1.1 | 40.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 1.1 | 30.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 1.1 | 31.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 1.1 | 12.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 1.1 | 22.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 1.0 | 22.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 1.0 | 2.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 1.0 | 10.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 1.0 | 31.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 1.0 | 2.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 1.0 | 23.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 1.0 | 45.7 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 1.0 | 21.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.9 | 25.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.9 | 7.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.9 | 11.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.9 | 6.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.9 | 41.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.9 | 13.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.9 | 16.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.9 | 62.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.9 | 89.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.8 | 10.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.8 | 69.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.8 | 26.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.8 | 33.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.8 | 16.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.8 | 11.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.8 | 7.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.8 | 97.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.8 | 27.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.7 | 1.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.7 | 14.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.7 | 4.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.7 | 4.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.7 | 7.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.6 | 22.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.6 | 67.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.6 | 8.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.6 | 4.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.6 | 10.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.6 | 4.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.6 | 66.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.6 | 8.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.6 | 191.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.6 | 50.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.5 | 3.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.5 | 8.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.5 | 2.9 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
| 0.5 | 23.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.5 | 9.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.5 | 11.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.5 | 8.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.5 | 19.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.4 | 13.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.4 | 3.9 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.4 | 5.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.4 | 16.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.4 | 1.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.4 | 13.3 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
| 0.4 | 39.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.4 | 1.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.4 | 4.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.3 | 5.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.3 | 5.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.3 | 4.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.3 | 14.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.3 | 12.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.3 | 3.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.3 | 4.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.3 | 7.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.3 | 5.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.3 | 1.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.3 | 5.5 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
| 0.3 | 1.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.3 | 3.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.3 | 2.3 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
| 0.2 | 0.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.2 | 1.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.2 | 3.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.2 | 1.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.2 | 3.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.2 | 3.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.2 | 4.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.2 | 4.8 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.2 | 5.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.2 | 2.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.2 | 3.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.2 | 6.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 7.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.1 | 7.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 1.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 2.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 4.9 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.1 | 4.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 1.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 3.5 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.1 | 0.7 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
| 0.1 | 1.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.0 | 1.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.0 | 1.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 0.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.0 | 1.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 1.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |